1. Pfizer and BioNTech submitted an emergency use authorization request to the FDA on April 26 for a COVID-19 vaccine booster for children ages 5-11.
2. Pfizer and French biotech company Valneva reported their Lyme disease vaccine candidate works better in children than in adults.
3. Pfizer recalled five lots of Accupril, a hypertension drug, April 22 due to the presence of a compound that may increase cancer risk.
4. Pfizer appointed David Denton its new CFO on April 11.
5. Pfizer is set to acquire ReViral, a drugmaker focusing on respiratory syncytial virus therapeutics, for $525 million.
6. Pfizer on March 21 issued a voluntary recall of its hypertension drug Accuretic and two generic versions of the drug because of elevated levels of a nitrosamine called N-nitroso-quinapril.
7. Pfizer and its partner, BioNTech, submitted an application to the FDA seeking emergency authorization for a second booster shot of their COVID-19 vaccine for people 65 and older, the company said March 15.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
